Micronucleated erythrocyte frequency in control and azidothymidine-treated Tk+/+, Tk+/- and Tk-/- mice

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 570, Issue 2, 2005, Pages 227-235

  Dobrovolsky, Vasily N ^a   McGarrity, Lynda J ^a   Vontungeln, Linda S ^a   Mittelstaedt, Roberta A ^a   Morris, Suzanne M ^a   Beland, Frederick A ^a   Heflich, Robert H ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Azidothymidine; DNA damage; Erythrocyte frequency; Micronucleus; Nucleoside analog reverse transcriptase inhibitor; Pyrimidine metabolism; Thymidine kinase

Indexed keywords

CELL NUCLEUS DNA; THYMIDINE; THYMIDINE DERIVATIVE; THYMIDINE KINASE; ZIDOVUDINE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ERYTHROCYTE; ERYTHROCYTE LIFESPAN; FEMALE; GENE DOSAGE; GENOTOXICITY; MALE; METABOLISM; MICRONUCLEUS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RETICULOCYTE;

EID: 13544277467     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2004.11.006     Document Type: Article

References (27)

1. E.M. Connor, R.S. Sperling, R. Gelber, P. Kiselev, G. Scott, M.J. O'Sullivan, R. VanDyke, M. Bey, W. Shearer, and R.L. Jacobson Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group New Engl. J. Med. 331 1994 1173 1180
2. N. Bhana, D. Ormrod, C.M. Perry, and D.P. Figgitt Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection Paediatr. Drugs 4 2002 515 553
3. W.C. Copeland, M.S. Chen, and T.S. Wang Human DNA polymerases alpha and beta are able to incorporate anti-HIV deoxynucleotides into DNA J. Biol. Chem. 267 1992 21459 21464
4. K.M. Ayers, D. Clive, W.E. Tucker Jr., G. Hajian, and P. de Miranda Nonclinical toxicology studies with zidovudine: genetic toxicity tests and carcinogenicity bioassays in mice and rats Fundam. Appl. Toxicol. 32 1996 148 158
5. M.C. Poirier, O.A. Olivero, D.M. Walker, and V.E. Walker Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs Toxicol. Appl. Pharmacol. 199 2004 151 161
6. S.D. Dertinger, D.K. Torous, and K.R. Tometsko Induction of micronuclei by low doses of azidothymidine (AZT) Mutat. Res. 368 1996 301 307
7. K.L. Witt, R.R. Tice, G.W. Wolfe, and J.B. Bishop Genetic damage detected in CD-1 mouse pups exposed perinatally to 3′-azido-3′- deoxythymidine or dideoxyinosine via maternal dosing, nursing, and direct gavage. II. Effects of the individual agents compared to combination treatment Environ. Mol. Mutagen. 44 2004 321 328
8. M.D. Phillips, B. Nascimbeni, R.R. Tice, and M.D. Shelby Induction of micronuclei in mouse bone marrow cells: an evaluation of nucleoside analogues used in the treatment of AIDS Environ. Mol. Mutagen. 18 1991 168 183
9. +/- mice treated neonatally with zidovudine and lamivudine Carcinogenesis 23 2002 1427 1432
10. R.A. Mittelstaedt, L.S. Von Tungeln, J.G. Shaddock, V.N. Dobrovolsky, F.A. Beland, and R.H. Heflich Analysis of mutations in the Tk gene of Tk(+/-) mice treated as neonates with 3′-azido-3′-deoxythymidine (AZT) Mutat. Res. 547 2004 63 69
11. Q. Meng, A.J. Grosovsky, X. Shi, and V.E. Walker Mutagenicity and loss of heterozygosity at the APRT locus in human lymphoblastoid cells exposed to 3′-azido-3′-deoxythymidine Mutagenesis 15 2000 405 410
12. Q. Meng, T. Su, O.A. Olivero, M.C. Poirier, X. Shi, X. Ding, and V.E. Walker Relationships between DNA incorporation, mutant frequency, and loss of heterozygosity at the TK locus in human lymphoblastoid cells exposed to 3′-azido-3′-deoxythymidine Toxicol. Sci. 54 2000 322 329
13. P.A. Furman, J.A. Fyfe, M.H. St Clair, K. Weinhold, J.L. Rideout, G.A. Freeman, S.N. Lehrman, D.P. Bolognesi, S. Broder, and H. Mitsuya Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase Proc. Natl. Acad. Sci. U.S.A. 83 1986 8333 8337
14. R. Brundiers, A. Lavie, T. Veit, J. Reinstein, I. Schlichting, N. Ostermann, R.S. Goody, and M. Konrad Modifying human thymidylate kinase to potentiate azidothymidine activation J. Biol. Chem. 274 1999 35289 35292
15. B. Munch-Petersen, L. Cloos, G. Tyrsted, and S. Eriksson Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides J. Biol. Chem. 266 1991 9032 9038
16. S.I. Gilles, S. Romain, P. Casellas, L. Ouafik, F. Fina, T. Combes, V. Vuaroquaux, J.F. Seitz, P. Bonnier, S. Galiegue, P. Carayon, and P.M. Martin Mutation analysis in the coding sequence of thymidine kinase 1 in breast and colorectal cancer Int. J. Biol. Markers 18 2003 1 6
17. V.N. Dobrovolsky, T. Bucci, R.H. Heflich, J. Desjardins, and F.C. Richardson Mice deficient for cytosolic thymidine kinase gene develop fatal kidney disease Mol. Genet. Metab. 78 2003 1 10
18. S.D. Dertinger, Y. Chen, R.K. Miller, K.J. Brewer, T. Smudzin, D.K. Torous, N.E. Hall, K.A. Olvany, F.G. Murante, and C.R. Tometsko Micronucleated CD71-positive reticulocytes: a blood-based endpoint of cytogenetic damage in humans Mutat. Res. 542 2003 77 87
19. D.K. Torous, N.E. Hall, F.G. Murante, S.E. Gleason, C.R. Tometsko, and S.D. Dertinger Comparative scoring of micronucleated reticulocytes in rat peripheral blood by flow cytometry and microscopy Toxicol. Sci. 74 2003 309 314
20. S.D. Dertinger, D.K. Torous, N.E. Hall, F.G. Murante, S.E. Gleason, R.K. Miller, and C.R. Tometsko Enumeration of micronucleated CD71-positive human reticulocytes with a single-laser flow cytometer Mutat. Res. 515 2002 3 14
21. J.L. Weaver, and D. Torous Flow cytometry assay for counting micronucleated erythrocytes: development process Methods 21 2000 281 287
22. J.T. MacGregor, C.M. Wehr, P.R. Henika, and M.D. Shelby The in vivo erythrocyte micronucleus test: measurement at steady state increases assay efficiency and permits integration with toxicity studies Fundam. Appl. Toxicol. 14 1990 513 522
23. V.N. Dobrovolsky, P.B. McKinzie, J.G. Shaddock, R.A. Mittelstaedt, R.H. Heflich, and B.L. Parsons Pms2 deficiency results in increased mutation in the Hprt gene but not the Tk gene of Tk(+/-) transgenic mice Mutagenesis 18 2003 365 370
24. B. Schuettengruber, A. Doetzlhofer, K. Kroboth, E. Wintersberger, and C. Seiser Alternate activation of two divergently transcribed mouse genes from a bidirectional promoter is linked to changes in histone modification J. Biol. Chem. 278 2003 1784 1793
25. S.T. Koury, M.C. Bondurant, G.L. Semenza, and M.J. Koury The use of in situ hybridization to study erythropoietin gene expression in murine kidney and liver Microsc. Res. Technol. 25 1993 29 39
26. J.R. Moffett, and M.A. Namboodiri Tryptophan and the immune response Immunol. Cell Biol. 81 2003 247 265
27. R. Schwarcz, and R. Pellicciari Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities J. Pharmacol. Exp. Ther. 303 2002 1 10